| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/20/2005 | WO2005005614A2 Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| 01/20/2005 | WO2005005612A2 Tag-1 and tag-2 proteins and uses thereof |
| 01/20/2005 | WO2005005610A2 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | WO2005005598A2 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 01/20/2005 | WO2005005596A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | WO2005005480A2 Taste receptors of the t1r family from domestic cat |
| 01/20/2005 | WO2005005479A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 01/20/2005 | WO2005005477A2 Stabilised insulin compositions |
| 01/20/2005 | WO2005005476A1 Modified epidermal growth factors |
| 01/20/2005 | WO2005005475A2 Appl proteins as rab5 effectors |
| 01/20/2005 | WO2005005474A1 Atopic dermatitis inducer |
| 01/20/2005 | WO2005005473A1 Methods to modulate the activity of the oestrogen receptor |
| 01/20/2005 | WO2005005472A1 Use of a novel eimeria gene and corresponding protein |
| 01/20/2005 | WO2005005471A2 Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 01/20/2005 | WO2005005470A2 Pectin methylesterase inhibitors for the preparation of fruit juices and derivatives |
| 01/20/2005 | WO2005005468A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 01/20/2005 | WO2005005467A2 Novel immune booster compound comprising an ef adenoviral sequence |
| 01/20/2005 | WO2005005466A2 Nucleic and protein sequences from the hxhv virus and uses thereof |
| 01/20/2005 | WO2005005464A2 Peptide-based linker |
| 01/20/2005 | WO2005005460A1 Method of washing and concentrating protein precipitates by means of a centrifugal field and fluidization conditions |
| 01/20/2005 | WO2005005459A1 Protein-refolding material |
| 01/20/2005 | WO2005004924A1 Active substance excipient system |
| 01/20/2005 | WO2005004910A2 Hcv vaccines |
| 01/20/2005 | WO2005004907A1 Packaged virus-like particles |
| 01/20/2005 | WO2005004899A2 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 01/20/2005 | WO2005004898A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 01/20/2005 | WO2005004800A2 Trypanosome derived apoptotic factors (taf) |
| 01/20/2005 | WO2005004798A2 Methods for treating lentivirus infections |
| 01/20/2005 | WO2005004792A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 01/20/2005 | WO2005004791A2 Compounds and methods for the treatment and prevention of bacterial infection |
| 01/20/2005 | WO2005004592A2 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/20/2005 | WO2005004585A2 Precise breeding |
| 01/20/2005 | WO2004101826A3 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi |
| 01/20/2005 | WO2004101615A3 Secreted polypeptide species associated with cardiovascular disorders |
| 01/20/2005 | WO2004101611A3 Peptides that bind to the erythropoietin receptor |
| 01/20/2005 | WO2004099248A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) |
| 01/20/2005 | WO2004099243A3 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof |
| 01/20/2005 | WO2004099235A3 Bacteriocins and novel bacterial strains |
| 01/20/2005 | WO2004097425A9 Method of selecting chemokine antagonists and agonists |
| 01/20/2005 | WO2004096857A3 Crystals of cytochrome p450 2c9, structures thereof and their use |
| 01/20/2005 | WO2004093788A9 Desmoglein 4 is a novel gene involved in hair growth |
| 01/20/2005 | WO2004092208A3 Sars-related proteins |
| 01/20/2005 | WO2004090551A3 Secreted polypeptide species associated with cardiovascular disorders |
| 01/20/2005 | WO2004089983A3 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/20/2005 | WO2004089981A3 Antitumor effect of mutant bik |
| 01/20/2005 | WO2004087952A8 Genes regulated by hydrogen peroxide stress |
| 01/20/2005 | WO2004087912A8 Inhibitor proteins of a protease and use thereof |
| 01/20/2005 | WO2004082608A3 Ligands for tgf-beta binding proteins and uses thereof |
| 01/20/2005 | WO2004078783A3 Enzymes involved in apoptosis |
| 01/20/2005 | WO2004075818A3 Stress specific molecular response in neurons |
| 01/20/2005 | WO2004065415A3 L-amino acid oxidase with cytotoxic activity from aplysia punctata |
| 01/20/2005 | WO2004057004A3 Plant genes and their use in controlling abcission in plants |
| 01/20/2005 | WO2004050698A3 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 01/20/2005 | WO2004048925A3 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 01/20/2005 | WO2004029088A3 Multidrug resistance proteins in drosophila and anopheles |
| 01/20/2005 | WO2004026265A3 Compositions and methods for treatment of herpesvirus infections |
| 01/20/2005 | WO2004022590A3 Immunogenic muc1 glycopeptides |
| 01/20/2005 | WO2004020466A8 Protein tyrosine phosphatase inhibitors |
| 01/20/2005 | WO2004015057A3 Mucin-immunoglobulin fusion proteins |
| 01/20/2005 | WO2004013636A3 Differential labeling for quantitative analysis of complex protein mixtures by trifunctional synthetic peptide based reagents with iodoacetamido groups |
| 01/20/2005 | WO2003094843A3 Cell adhesion and extracellular matrix proteins |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003026494A3 Galectins-1-and-4 in tumor development |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050015832 Coding for polyol carriers in plants or fungi in polyols with main chain of 5 to 8 carbons with 6 the ideal such as manniotol |
| 01/20/2005 | US20050015831 Transgenic monocot plant comprising recombinant nucleic acid encoding signal peptide linked to promoter which targets expression of the polypeptide to intracellular body |
| 01/20/2005 | US20050015828 Plants having enhanced nitrogen assimilation/metabolism |
| 01/20/2005 | US20050015826 Hypoallergenic transgenic soybeans |
| 01/20/2005 | US20050015824 Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| 01/20/2005 | US20050015822 Mass 1 gene, a target for anticonvulsant drug development |
| 01/20/2005 | US20050015821 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use |
| 01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
| 01/20/2005 | US20050015819 Generating animal model with enhanced tau protein expression; for use as tool in treatment and prevention of neurodegenerative diseases |
| 01/20/2005 | US20050015232 Computer-based methods of designing molecules |
| 01/20/2005 | US20050014933 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
| 01/20/2005 | US20050014710 Compositions and methods relating to prostate specific genes and proteins |
| 01/20/2005 | US20050014696 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014689 Remedies for life style-related diseases or cibophobia and method of screening the same |
| 01/20/2005 | US20050014688 Inducer of apoptosis |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014683 Solvent extraction from plant |
| 01/20/2005 | US20050014679 Genetic engineered insulin; antidiabetic agents |
| 01/20/2005 | US20050014290 Binding proteins as biosensors |
| 01/20/2005 | US20050014266 Transcription regulator for use in controlling vectoral expression of genes associated with conferring disease, freeze, salt resistance and drought resistant crops |
| 01/20/2005 | US20050014265 Transgenic plant comprising potassium transport protein sequences for use in generation of drought, cold, and/or salt tolerant plants |
| 01/20/2005 | US20050014263 Materials and methods for delivery and expression of heterologous DNA in vertebrate cells |
| 01/20/2005 | US20050014262 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 01/20/2005 | US20050014261 Chimaeric phages |
| 01/20/2005 | US20050014260 Fusion protein delivery system and uses thereof |
| 01/20/2005 | US20050014239 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/20/2005 | US20050014234 Genes from the corynebacterium glutamicum coding for regulatory proteins |
| 01/20/2005 | US20050014229 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014226 Using monoclonal antibodies specific to membrane bound receptors as diagnostic indicator of abnormal cell proliferation; tumor diagnosis; antitumor agents |
| 01/20/2005 | US20050014225 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/20/2005 | US20050014224 GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| 01/20/2005 | US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| 01/20/2005 | US20050014220 Lectin-like domain of thrombomodulin and its therapeutic use |